Scholars@Duke
Annick Desjardins

Annick Desjardins

Professor of Neurosurgery
Neurosurgery, Neuro-Oncology
annick.desjardins@duke.edu
Duke Box 3624, Durham, NC 27710
the Preston Robert Tisch Brain, Rm. 047 Baker House, DUMC 3624, Durham, NC 27710

Current Duke Appointments & Affiliations

Professor of Neurosurgery · 2021 - Present Neurosurgery, Neuro-Oncology, Neurosurgery
Professor in Neurology · 2021 - Present Neurology, Comprehensive Neurology, Neurology
Member of the Duke Cancer Institute · 2003 - Present Duke Cancer Institute, Institutes and Centers

Recent News Items

Published June 6, 2016
Duke’s Poliovirus Therapy Shows Survival Benefit in Early Patients
Published May 16, 2016
Poliovirus Therapy Wins 'Breakthrough' Status
Published June 1, 2015
Poliovirus Study Finds That Less Is More in Brain Tumor Treatment

View All News Items

Recent Scholarly Works

STELLAR: Phase III, Randomized, Open-Label Study of Eflornithine Plus Lomustine Versus Lomustine Alone in Patients With Recurrent Grade 3 Astrocytoma.

Journal article J Clin Oncol · March 10, 2026 PURPOSE: STELLAR (ClinicalTrials.gov identifier: NCT02796261) was a phase III, randomized, open-label trial of eflornithine + lomustine versus lomustine monotherapy in patients with recurrent grade 3 astrocytoma. METHODS: At trial initiation, eligibility c ... Full text Link to item Cite

Lymphotropic Virotherapy Induces DC and High Endothelial Venule Inflammation, Promoting the Antitumor Efficacy of Intratumor Virus Administration.

Journal article Cancer Immunol Res · February 3, 2026 Tumor-draining lymph nodes are a pivotal site for antitumor T-cell priming. However, their mechanistic roles in cancer immune surveillance and immunotherapy response remain poorly defined. Intratumor (IT) virotherapy generates antitumor T-cell immunity thr ... Full text Link to item Cite

Clinical trial of feasibility for mindfulness intervention for patients with newly diagnosed high grade glioma.

Journal article J Neurooncol · November 5, 2025 PURPOSE: With a bleak prognosis for malignant glioma, maintaining quality of life (QoL) and decreasing distress are essential in patient clinical care. Mindfulness meditation is a mind-body therapy that is being investigated as a non-pharmacological strate ... Full text Open Access Link to item Cite
View All Scholarly Works

Recent Grants

McCain/Bayh Glioblastoma Consortium

Clinical TrialCo Investigator · Awarded by Department of Defense · 2025 - 2029

Circle of Service Foundation Challenge Grant

Institutional SupportCo Investigator · Awarded by Circle of Service Foundation · 2023 - 2028

View All Grants

Education

University of Sherbrooke (Canada) · 1998 M.D.